Interestingly, “beiging” of eWAT correlated with increased expression of Wnt10b and IGFBP2, two endocrine/paracrine factors recognized for their anti-obesity and bone anabolic activity [44]–[46]. The gene discussed is WNT10B; the disease is Obesity.